Carole Guillonneau, n/a

Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, F-44000 Nantes, France; LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, France, France

Poster(s):

• W3 - Anti-CD45RC Antibody Immunotherapy Prevents and Treats Experimental Autoimmune Poly Endocrinopathy Candidiasis Ectodermal Dystrophy Syndrome
  Wednesday, June 22, 2022

  6:15 PM – 7:30 PM PT

• Th1 - Clinical Grade CD8+T Regulatory Cells Moving Forward in Human Transplantation
  Thursday, June 23, 2022

  6:15 PM – 7:30 PM PT

• W19 - MHC-deficient CD8+ Tregs as Universally Compatible Cell Therapy
  Wednesday, June 22, 2022

  6:15 PM – 7:30 PM PT

• W61 - Expression of TNFR2 and CD29 Define a Highly Suppressive Subset of Human CD8+ T Regulatory Cells
  Wednesday, June 22, 2022

  6:15 PM – 7:30 PM PT

• Tu44 - Immunotherapy Using IL-34 for the Treatment of GvHD and Solid Organ Rejection: Strategies for its Optimisation
  Tuesday, June 21, 2022

  6:15 PM – 7:45 PM PT

• Th168 - Differentiation of Human iPSc into Functional Thymic Organoids for in vitro T Cell Generation and Cell Therapy
  Thursday, June 23, 2022

  6:15 PM – 7:30 PM PT